Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Invitae Corporation | NVTA | NYSE | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0891 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0891 | 0.0891 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.081 - 1.67 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.0891 | USD |
Invitae Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 25.53M | - | - | - | -0.82 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Invitae News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/06/2024 | 07:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/06/2024 | 16:07 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/30/2024 | 06:00 | PR Newswire (US) | Invitae Partners with BridgeBio Pharma to Harness Genetic.. |
| 1/29/2024 | 15:01 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 1/24/2024 | 15:34 | Edgar (US Regulatory) | Form 8-K/A - Current report: [Amend] |
| 1/22/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/22/2024 | 06:00 | PR Newswire (US) | Invitae Completes Sale of Reproductive Health Assets to.. |
| 1/18/2024 | 15:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/21/2023 | 20:20 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/21/2023 | 20:14 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/14/2023 | 15:29 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/13/2023 | 15:07 | PR Newswire (US) | Invitae Divests Ciitizen Health Data Platform and Implements.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NVTA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.3823 | 0.3947 | 0.081 | 0.1071738 | 50,116,082 | -0.2932 | -76.69% |
| 6 Months | 0.5133 | 0.7639 | 0.081 | 0.4828773 | 8,660,719 | -0.4242 | -82.64% |
| 1 Year | 1.28 | 1.67 | 0.081 | 0.8369824 | 9,348,838 | -1.19 | -93.04% |
| 3 Years | 36.68 | 38.42 | 0.081 | 5.40 | 8,179,412 | -36.59 | -99.76% |
| 5 Years | 23.27 | 61.59 | 0.081 | 10.71 | 5,989,857 | -23.18 | -99.62% |
Invitae Description
| Invitae Corp operates as a genetic information company in diagnostic and research industry. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. |
